Full Press Release Details
Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York.
RARE
Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York
Key Takeaway: Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia